We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Against High-Temperature Test for NDMA in Ranitidine Drugs
FDA Warns Against High-Temperature Test for NDMA in Ranitidine Drugs
The FDA warned manufacturers of ranitidine products not to use a high-temperature test for N-Nitrosodimethylamine (NDMA) because it actually generates high levels of the impurity.